A Prospective Observational Study on Analyzing Lung Cancer Gene Mutation Variant Allele Frequency (VAF) and Its Correlation with Treatment Efficacy
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High-sensitivity lung cancer gene panel tests can detect low variant allele frequencies (VAF) of mutations. This is crucial for effective molecular-targeted therapy, even when VAF is below 10% in non-small cell lung cancer patients.
Area Of Science
- Oncology
- Genetics
- Molecular Diagnostics
Background
- The variant allele frequency (VAF) of gene mutations and its correlation with molecular-targeted drug efficacy remain areas of investigation.
- Accurate detection of mutations is critical for guiding targeted therapies in cancer treatment.
Purpose Of The Study
- To evaluate the utility of a high-sensitivity next-generation sequencing (NGS) lung cancer gene panel test using cytology samples.
- To analyze the distribution of VAF in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations.
- To assess the relationship between VAF and the duration of initial molecular-targeted drug administration.
Main Methods
- A joint study conducted between May 2020 and January 2022.
- Analysis of cytology samples from 196 patients diagnosed with NSCLC.
- Utilized a high-sensitivity NGS gene panel test to detect gene mutations and determine VAF.
- Categorized patients into groups based on VAF (≥10% and <10%) for comparison of drug administration duration.
Main Results
- Gene mutations were detected in 58.2% of NSCLC patients, with a higher detection rate in adenocarcinomas (68.7%).
- Among 59 patients with EGFR mutations, 35 received molecular-targeted drugs as initial treatment.
- No statistically significant difference in the duration of molecular-targeted drug administration was observed between patients with VAF ≥10% (17 months) and VAF <10% (14 months) (p=0.7).
- Twenty-seven percent of patients had a VAF < 10%, with 17.3% having VAF < 6%.
Conclusions
- Highly sensitive gene panel testing is important for detecting low VAF mutations in NSCLC at initial diagnosis.
- Sufficient therapeutic effects can be achieved with molecular-targeted drugs even in patients with low VAF gene mutations.
- Further prospective studies with larger cohorts are warranted to validate these findings.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Descriptive Statistics: These provide basic...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...